Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 22, which means every article in Journal of Vaccines & Vaccination has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
59 | 65 | 71 | 11 | 19 |
Year wise citations received |
174 | 249 | 218 | 197 | 194 |
Journal total citations count | 2051 |
Journal Impact Factor | 2.87 |
Journal 5 years Impact Factor | 3.73 |
Journal CiteScore | 4.69 |
Journal h-index | 22 |
Framework for Optimal Global Vaccine Stockpile Design for Vaccine?Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples
Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies
Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.
Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis.
Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis
RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination
Novel Aspects and Strategies in Vaccination
Immunisation and Vaccines
RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination
Novel Aspects and Strategies in Vaccination
RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination
Novel Aspects and Strategies in Vaccination
Systematic Review of Measles and Rubella Serology Studies
Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II: Modeling and Managing the Risks of Measles and Rubella
Modeling Poliovirus Risks and the Legacy of Polio Eradication
Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention.
Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories
Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies